Literature DB >> 34825909

Self-glucose feeding hydrogels by enzyme empowered degradation for 3D cell culture.

Mehrzad Zargarzadeh1, A Sofia Silva1, Cláudia Nunes1,2, Manuel A Coimbra2, Catarina A Custódio1, João F Mano1.   

Abstract

Hydrogels have been used in combination with cells for several biomedical and biotechnological applications. Nevertheless, the use of bulk hydrogels has exhibited severe limitations in diffusion of oxygen, nutrients, and metabolites. Here, a support for cell culture is reported where glucose is generated in situ by the own hydrogel degradation, allowing cell survival and function while promoting tissue growth. For this purpose, laminaran (or laminarin)-based hydrogels were fabricated, immobilizing the adequate enzymes to obtain structural platforms for 3D cell culture and providing glucose feeding for metabolic activity of cells through polysaccharide degradation. We demonstrate that tumor A549 cells and human mesenchymal stem cells (hMSCs) can use the glucose resultant from the hydrogel degradation to survive and grow in non-added glucose cell culture medium. Additionally, in vivo biocompatibility and biodegradability of laminaran-based hydrogels were explored for the first time. The self-feeding hydrogels exhibited high potential in cell survival compared to native cell-laden laminaran hydrogels over two weeks of sub-cutaneous implantation. Such bioscaffolds with enzyme-empowered degradation capacity can be applied in diverse biotechnological contexts such as tissue regeneration devices, biofactories, disease models, and cell delivery systems.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34825909     DOI: 10.1039/d0mh01982h

Source DB:  PubMed          Journal:  Mater Horiz        ISSN: 2051-6347            Impact factor:   13.266


  1 in total

Review 1.  From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases.

Authors:  Catarina Caseiro; Joana Nunes Ribeiro Dias; Carlos Mendes Godinho de Andrade Fontes; Pedro Bule
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.